Zdrowie i gospodarka · 30/12/1997

FDA Releases Draft Guidance on Food-Effect Bioavailability and Bioequivalence Studies for Pharmaceutical Industry

The FDA has made available a draft guidance document for the pharmaceutical industry, outlining requirements for conducting food-effect bioavailability and bioequivalence studies for new drug applications and other submissions.